Circassia
Latest round
- Series D
Last raised
- Sep 2010
Total raised
- $152M
Investors
- 5
About Circassia
Circassia Limited is a specialty biopharmaceutical company, focused on developing immunotherapies to treat allergies, prevent organ transplant rejection and improve recovery from surgeries.
Who invested in Circassia
5 investors across 4 rounds
See all investors in Circassia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Circassia
Who invested in Circassia?
Circassia has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Circassia raised?
Circassia has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Circassia last raise money?
Circassia's most recent round on record is a Series D, in Sep 2010.
What does Circassia do?
Circassia Limited is a specialty biopharmaceutical company, focused on developing immunotherapies to treat allergies, prevent organ transplant rejection and improve recovery from surgeries.
Where is Circassia headquartered?
Circassia is headquartered in Oxford, UK.
Which VCs invest in companies like Circassia?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Circassia's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Circassia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.